Global Lung Cancer Treatment Market Size, Share, Growth, Trends, and Forecast (2024 - 2031)
Global Lung Cancer Treatment Market Scope: Historical Data (2021 – 2022), Base Year (2023), Forecast Period (2024 – 2031)
Market Segmentation: By Therapy (Targeted Therapy, Immunotherapy, and Chemotherapy), Cancer Type (Non-Small cell lung cancer (NSCLC), and Small cell lung cancer (SCLC)), Distribution Channel (Hospital, Retail, and Online), and Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)
Market Overview
The Global Lung Cancer Treatment Market was valued at USD 28,433.0 million in 2023 and is expected to reach USD 81,678.6 million by 2031 while growing at a CAGR of 14.1% during the forecast period (2024-2031).
*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report
Market Dynamics
This section of the report will analyze various driving and restraining factors that are expected to have a significant impact on the global lung cancer treatment market growth. Treatment for lung cancer varies based on its type and stage of progression. Non-small cell lung cancer patients may undergo surgery, chemotherapy, radiation therapy, targeted therapy, or a combination thereof. Conversely, small cell lung cancer patients typically receive treatment involving radiation therapy and chemotherapy.
Continuous advancements in diagnostic techniques, treatment modalities, and surgical procedures, alongside the increasing incidence of lung cancer and the implementation of growing awareness and screening programs, propel market growth. However, obstacles such as the high cost of treatment and regulatory hurdles impede further market expansion.
Furthermore, the global lung cancer treatment industry will be analyzed through various tools including PESTLE analysis, and Porter’s analysis.
Segmentation – By Therapy Analysis
The Global Lung Cancer Treatment Market is segmented among Targeted Therapy, Immunotherapy, and Chemotherapy, based on Therapy. In 2023, Targeted Therapy accounted for the majority of the market share*.
*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report
Segmentation – By Cancer Type Analysis
The Global Lung Cancer Treatment Market is segmented among Non-Small cell lung cancer (NSCLC), and Small cell lung cancer (SCLC), based on Cancer Type. In 2023, Non-Small cell lung cancer (NSCLC) accounted for the majority of the market share*.
*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report
Global Lung Cancer Treatment Market: Regional Analysis
Based on region, the market is divided into six regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. In 2023, North America dominated the market with the highest market share, while Asia Pacific is expected to grow with the highest CAGR during the forecast period (2024 – 2031).
*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report
Competitive Landscape
Some of the key players operating in the market are F. Hoffmann-La Roche, Eli Lilly and Company, Celgene Corporation, AstraZeneca, Pfizer Inc, Novartis AG, Sanofi, Boehringer Ingelheim, Bristol-Myers Squibb Company, Takeda, Merck & Co.
Table of Contents:
1. Research Methodology and Market Scope
Research Methodology
Market Scope
2. Executive Summary
3. Global Lung Cancer Treatment Market Dynamics
Drivers
Restraints
Opportunity
4. Global Lung Cancer Treatment Industry Analysis
PEST Analysis
Porter's Five Force Analysis
Recent Deals Analysis
5. Global Lung Cancer Treatment Market Segmentation, By Therapy
Global Lung Cancer Treatment Market Share Analysis, By Therapy
Global Lung Cancer Treatment Market Growth Analysis, By Therapy
Global Lung Cancer Treatment Market Trends, By Therapy
o Targeted Therapy
o Immunotherapy
o Chemotherapy
6. Global Lung Cancer Treatment Market Segmentation, By Cancer Type
Global Lung Cancer Treatment Market Share Analysis, By Cancer Type
Global Lung Cancer Treatment Market Growth Analysis, By Cancer Type
Global Lung Cancer Treatment Market Trends, By Cancer Type
o Non-Small cell lung cancer (NSCLC)
o Small cell lung cancer (SCLC)
7. Global Lung Cancer Treatment Market Segmentation, By Distribution Channel
Global Lung Cancer Treatment Market Share Analysis, By Distribution Channel
Global Lung Cancer Treatment Market Growth Analysis, By Distribution Channel
Global Lung Cancer Treatment Market Trends, By Distribution Channel
o Hospital
o Retail
o Online
8. Global Lung Cancer Treatment Market Segmentation, By Region
Global Lung Cancer Treatment Market Share Analysis, By Region
Global Lung Cancer Treatment Market Growth Analysis, By Region
Global Lung Cancer Treatment Market Trends, By Region
o North America
o Europe
o Asia Pacific
o Latin America
o Middle East
o Africa
9. Competitive Landscape
F. Hoffmann-La Roche*
o Company Overview
o Financial Performance
o Key Development/Strategies
o SWOT Analysis
Eli Lilly and Company
Celgene Corporation
AstraZeneca
Pfizer Inc
Novartis AG
Sanofi
Boehringer Ingelheim
Bristol-Myers Squibb Company
Takeda
Merck & Co
*Similar analysis will be provided for each company listed above.
